{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.title}}
{{item.text}}
Regulatory considerations when modernizing the pharma supply chain
Oversight of the pharmaceutical supply chain is significantly transforming across the executive, legislative and regulatory domains. As national vulnerabilities and supply chain disruptions garner public and political attention, calls for even greater transparency and momentum for change are likely to continue.
Understanding three key shifts in oversight of the pharmaceutical supply chain can help guide strategic supply chain efforts:
- Continued executive and congressional attention
- Expanded reporting requirements
- Implementation challenges for Drug Quality and Security Act (DQSA)
{{filterContent.facetedTitle}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Follow us
